Stenotrophomonas maltophilia: Difference between revisions

From IDWiki
Stenotrophomonas maltophilia
No edit summary
m (Text replacement - "[[Cellular shape::" to "[[Shape::")
 
(11 intermediate revisions by the same user not shown)
Line 1: Line 1:
== Microbiology ==
==Background==


===Microbiology===
* Aerobic, non-fermentive, Gram negative, catalase positive, oxidase negative


*Aerobic, non-fermentive, catalase [[Catalase::positive]], oxidase [[Oxidase::negative]], [[Stain::Gram-negative]] [[Shape::bacillus]]
== Clinical Presentation ==
*Multiple mechanisms of resistance
**RND, MfsA, and Sme-related efflux pumps
**''Sul'' or ''dfrA'' genes (TMP-SMX resistance)
**β-lactamases
**Aminoglycoside-modifying enzymes


==Clinical Manifestations==
* Nosocomial infections with high mortality and high antibiotic resistance


*Nosocomial infections with high mortality and high antibiotic resistance
== Management ==


==Management==
* Limited antibiotic options:
** [[Levofloxacin]] (and other FQs)
** [[TMP-SMX]] (Septra)
** [[Doxycycline]]
** Maybe also ticarcillin-clavulanate and [[ceftazidime]]


*Limited antibiotic options
*Therapy should be guided by antimicrobial susceptibility testing
*Antistenotrophomonal antibiotics:
**[[Is treated by::TMP-SMX]] 15 mg/kg split q8h (preferred agent, if susceptible)
**[[Is treated by::Fluoroquinolones]], including [[Is treated by::moxifloxacin]], [[Is treated by::levofloxacin]], and [[Is treated by::ciprofloxacin]] (though develops resistance quickly on monotherapy)
**[[Is treated by::Minocycline]], [[Is treated by::doxycycline]], and [[Is treated by::tigecycline]]
**[[Is treated by::Ticarcillin-clavulanate]] and [[Is treated by::ampicillin-sulbactam]]
**[[Is treated by::Ceftazidime]] and [[Is treated by::ceftazidime-avibactam]]
**[[Is treated by::Colistin]], though high rates of resistance
**Possibly [[Is treated by::ceftriaxone]]

{{DISPLAYTITLE:''Stenotrophomonas maltophilia''}}
[[Category:Gram-negative bacilli]]
[[Category:Gram-negative bacilli]]

Latest revision as of 18:24, 13 October 2020

Background

Microbiology

  • Aerobic, non-fermentive, catalase positive, oxidase negative, Gram-negative bacillus
  • Multiple mechanisms of resistance
    • RND, MfsA, and Sme-related efflux pumps
    • Sul or dfrA genes (TMP-SMX resistance)
    • β-lactamases
    • Aminoglycoside-modifying enzymes

Clinical Manifestations

  • Nosocomial infections with high mortality and high antibiotic resistance

Management